These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8236864)

  • 1. [Damage caused by monoclonal immunoglobulins and possibilities of therapy. 2].
    Adam Z
    Vnitr Lek; 1993 Oct; 39(10):1013-21. PubMed ID: 8236864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Damage caused by monoclonal immunoglobulins and possibilities of therapy. 1].
    Adam Z
    Vnitr Lek; 1993 Aug; 39(8):817-27. PubMed ID: 8212634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light chains: heavy burden in kidney transplantation.
    Heher EC; Spitzer TR; Goes NB
    Transplantation; 2009 Apr; 87(7):947-52. PubMed ID: 19352111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal gammopathies].
    Fain O
    Rev Prat; 2006 Jan; 56(1):40-50. PubMed ID: 16548248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropathy, monoclonal gammopathy and autoantibodies: how to establish a link?].
    Stojkovic T
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S45-53. PubMed ID: 18087229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Skin manifestations of monoclonal gammopathies].
    Hello M; Barbarot S; Néel A; Connault J; Graveleau J; Durant C; Decaux O; Hamidou M
    Rev Med Interne; 2014 Jan; 35(1):28-38. PubMed ID: 24070793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
    Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
    Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin light (heavy)-chain deposition disease: from molecular medicine to pathophysiology-driven therapy.
    Ronco P; Plaisier E; Mougenot B; Aucouturier P
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1342-50. PubMed ID: 17699367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody activities of monoclonal immunoglobulins].
    Mariette X
    Rev Prat; 1993 Feb; 43(3):281-4. PubMed ID: 8502955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
    J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies in patients with monoclonal gammopathies.
    Carlizzi G; Ciarla MV; Di Luzio A; Labriola R; Frattolillo D; Spiridigliozzi P; Masala C; Strom R
    Ann N Y Acad Sci; 2007 Jun; 1107():206-11. PubMed ID: 17804548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraovarian hemangioma with immunoglobulin deposits in a patient with monoclonal gammopathy of uncertain significance and osteolytic lesions.
    Suárez-Vilela D; Izquierdo-Garcia FM
    Virchows Arch; 2005 Jan; 446(1):85-7. PubMed ID: 15455229
    [No Abstract]   [Full Text] [Related]  

  • 13. Histopathological atlas of renal diseases: light chain deposition disease.
    Ferrario F; Rastaldi MP
    J Nephrol; 2005; 18(5):499-502. PubMed ID: 16299674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New physiopathological findings in paraproteinemias].
    Trendelenburg M; Schifferli JA
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1639-42. PubMed ID: 11103433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of polyclonal immunoglobulin production by M-proteins shows isotype specificity.
    Wang L; Young DC
    Ann Clin Lab Sci; 2001 Jul; 31(3):274-8. PubMed ID: 11508831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light chains, casts, sheets and fibrils: monoclonal immunoglobulin diseases and immunotactoid/fibrillary glomerulopathy.
    Dember LM
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1320-1. PubMed ID: 17699364
    [No Abstract]   [Full Text] [Related]  

  • 17. Free light chains in plasma of patients with light chain amyloidosis and non-amyloid light chain deposition disease. High proportion and heterogeneity of disulfide-linked monoclonal free light chains as pathogenic features of amyloid disease.
    Kaplan B; Ramirez-Alvarado M; Sikkink L; Golderman S; Dispenzieri A; Livneh A; Gallo G
    Br J Haematol; 2009 Mar; 144(5):705-15. PubMed ID: 19076171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulins dramatically reverse systemic capillary leak syndrome.
    Lambert M; Launay D; Hachulla E; Morell-Dubois S; Soland V; Queyrel V; Fourrier F; Hatron PY
    Crit Care Med; 2008 Jul; 36(7):2184-7. PubMed ID: 18552679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of intravenous immunoglobulins on systemic capillary leak syndrome in patients with monoclonal gammopathy.
    Shin JI; Lee JS
    Crit Care Med; 2009 Feb; 37(2):795; author reply 795. PubMed ID: 19325398
    [No Abstract]   [Full Text] [Related]  

  • 20. The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies.
    Rongioletti F; Patterson JW; Rebora A
    J Cutan Pathol; 2008 Aug; 35(8):705-21. PubMed ID: 18331570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.